Teva Pharmaceuticals USA, Inc. et al v. Sandoz, Inc. et al
Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Teva Neuroscience, Inc. and Yeda Research and Development Co. Ltd. |
Sandoz, Inc., Sandoz International GmbH, Novartis AG and Momenta Pharmaceuticals, Inc. |
1:2008cv07611 |
August 28, 2008 |
US District Court for the Southern District of New York |
Patent Office |
XX Out of U.S. |
James C. Francis |
Barbara S. Jones |
None |
Federal Question |
35:271 Patent Infringement |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 336 OPINION AND ORDER: For the reasons provided within, the Court finds that both Mylan's and Sandoz's ANDA infringe all of the asserted claims, and that none of the asserted claims are invalid or unenforceable. Teva is ordered to submit a proposed judgment incorporating the rulings contained in this Opinion and Order to the Court on or before July 2, 2012. (Signed by Judge Barbara S. Jones on 6/22/2012) Filed In Associated Cases: 1:08-cv-07611-BSJ -AJP, 1:09-cv-08824-BSJ(laq) |
Filing 41 STIPULATED PROTECTIVE ORDER...regarding procedures to be followed that shall govern the handling of confidential material.... (Signed by Judge Barbara S. Jones on 4/10/2009) (jpo) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.